Table: Kaken Pharmaceutical -6-MTH group results

KAKEN PHARMACEUTICAL

06/11/2015 04:30

Nov 6 (Reuters)-  
             Kaken Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2015        Sep 30, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             54.97               44.23           107.90     
                 (+24.3 pct)         (+1.2 pct)       (+14.9 pct)  
  Operating         18.44                8.81            32.20     
                (+109.4 pct)         (+19.7 pct)      (+56.1 pct)  
  Recurring         18.57                8.68            32.40     
                (+114.1 pct)         (+20.3 pct)      (+58.9 pct)  
  Net               12.48                5.64            19.20     
                (+121.4 pct)         (+22.6 pct)      (+58.4 pct)  
  EPS            301.39 yen          134.56 yen       463.66 yen   
  Ann Div                             59.00 yen                    
  -Q2 div         34.00 yen           27.00 yen                    
  -Q4 div                             32.00 yen        78.00 yen   
   
  NOTE - Kaken Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T  
  ((Tokyo Headline News Desk +813 6441 1812))